Hillman Capital Management, Inc. Gsk PLC Transaction History

Hillman Capital Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$42.05 - $47.77 $48,147 - $54,696	1,145 Added 0.49%	236,834 $10.3 Million
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $104,195 - $123,646	2,590 Added 1.11%	235,689 $10.3 Million
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $337,361 - $393,154	-8,677 Reduced 3.59%	233,099 $10.3 Million
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $318,116 - $353,955	8,201 Added 3.51%	241,776 $9.24 Million
Q2 2021 Aug 16, 2021	BUY	$36.52 - $41.46 $55,145 - $62,604	1,510 Added 0.65%	233,575 $9.3 Million
Q1 2021 May 14, 2021	BUY	$34.27 - $40.01 $7.76 Million - $9.06 Million	226,445 Added 4029.27%	232,065 $8.28 Million
Q4 2020 Feb 12, 2021	BUY	$34.07 - $39.94 $191,473 - $224,462	5,620 New	5,620 $207,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Hillman Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hillman Capital Management, Inc. with notifications on news.